Tag: AI Drug Discovery
Chai Discovery raises $400 million Series C for AI drug design
The startup behind AI molecule models used by Lilly, Novartis and Pfizer hits a $3.8 billion valuation.
Insilico and SK Biopharm ink $2.5 billion AI drug discovery deal
The partnership targets neuroimmune and CNS disorders using Insilico's Pharma.AI engine, with $18 million in upfront payments and milestone-based upside.
OpenAI launches GPT-Rosalind for life sciences research
The frontier reasoning model is designed to accelerate drug discovery and biological research across chemistry, protein engineering, and genomics.
Chai Discovery raises $400M at $3.8B valuation for AI drug design
The AI biotech startup triples its valuation in eight months with backing from Lilly, Pfizer and Novartis partnerships.
How Machine Learning Is Reshaping Pharmaceutical R&D
AI is reshaping pharmaceutical R&D from target identification through clinical trial optimization, compressing drug discovery timelines and unlocking therapeutic targets…
ARPA-H Awards $160 Million for AI-Enabled Personalized Gene Editing to Tackle Rare Diseases
ARPA-H has awarded up to $160 million to seven research teams to build AI-driven platforms for creating custom, individualized gene…